Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats

Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats

Abstract Background Insulin resistance (IR) is closely associated with the progression of hepatocellular carcinoma (HCC). Acyclic retinoid (ACR) targets retinoid X receptor α and reportedly prevents HCC recurrence in clinical practice. Angiotensin-II receptor blocker (ARB) can also inhibit experimen...

Full description

Bibliographic Details
Main Authors: Norihisa Nishimura, Kosuke Kaji, Mitsuteru Kitade, Yosuke Aihara, Shinya Sato, Kenichiro Seki, Yasuhiko Sawada, Hiroaki Takaya, Yasushi Okura, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Akira Mitoro, Hitoshi Yoshiji
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Cancer
Subjects:
Acyclic retinoid
ARB
Hepatocarcinogenesis
Chemoprevention
Insulin resistance
Online Access:http://link.springer.com/article/10.1186/s12885-018-5099-6

Internet

http://link.springer.com/article/10.1186/s12885-018-5099-6

Similar Items